Form 4 Tracker
Enliven Therapeutics, Inc.
ELVN

31 insider filings · Latest: Aug 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 19, 2025May 19 8:21 PMLyssikatos Joseph P
Proposed Sale
5,000$16.86$84.3K

View →

May 7, 2025May 7 8:11 PMPatel Anish
Proposed Sale
6,667$19.69$131.3K

View →

May 1, 2025May 1 8:03 PMLyssikatos Joseph P
Proposed Sale
7,500$18.94$142.1K

View →

May 1, 2025May 1 8:02 PMKintz Samuel
Proposed Sale
7,500$18.94$142.1K

View →

Apr 21, 2025Apr 21 8:28 PMLyssikatos Joseph P
Proposed Sale
5,000$16.53$82.7K

View →

Apr 17, 2025Apr 17 8:19 PMKintz Samuel
Proposed Sale
5,000$16.07$80.3K

View →

Apr 14, 2025Apr 14 8:54 PMPatel Anish
Proposed Sale
2,010$16.51$33.2K

View →

Apr 14, 2025Apr 14 8:48 PMPatel Anish
Proposed Sale
2,010$16.51$33.2K

View →

Apr 7, 2025Apr 7 8:09 PMPatel Anish
Proposed Sale
6,667$18.69$124.6K

View →

Mar 27, 2025Mar 27 8:01 PMHohl Benjamin
Proposed Sale
4,250$20.58$87.5K

View →

Mar 19, 2025Mar 19 8:18 PMLyssikatos Joseph P
Proposed Sale
12,500$20.28$253.5K

View →

Mar 18, 2025Mar 18 9:33 PMKintz Samuel
Proposed Sale
21,531$21.04$453.0K

View →

Mar 18, 2025Mar 18 9:22 PMKintz Samuel
Proposed Sale
21,531$21.04$453.0K

View →

Mar 18, 2025Mar 18 8:14 PMKintz Samuel
Proposed Sale
21,531$21.04$453.0K

View →

Mar 18, 2025Mar 18 8:06 PMKintz Samuel
Proposed Sale
21,531$21.04$453.0K

View →

Mar 17, 2025Mar 17 8:14 PMKintz Samuel
Proposed Sale
12,500$20.74$259.3K

View →

Mar 17, 2025Mar 17 8:08 PMPatel Anish
Proposed Sale
2,500$20.74$51.9K

View →

Mar 17, 2025Mar 17 8:04 PMPatel Anish
Proposed Sale
2,500$20.74$51.9K

View →

Mar 7, 2025Mar 7 9:18 PMPatel Anish
Proposed Sale
6,667$21.46$143.1K

View →

Feb 27, 2025Feb 27 9:10 PMHohl Benjamin
Proposed Sale
4,250$20.28$86.2K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 12, 2026Feb 18 12:52 AMJoseph P LyssikatosCHIEF SCIENTIFIC OFFICER
Grant/Award
112,500$27.16112,500(D)

View →

Feb 12, 2026Feb 18 12:49 AMBenjamin HohlCHIEF FINANCIAL OFFICER
Grant/Award
150,000$27.16150,000(D)

View →

Feb 12, 2026Feb 18 12:47 AMHelen Louise CollinsCHIEF MEDICAL OFFICER
Grant/Award
150,000$27.16150,000(D)

View →

← Previous

Page 2 of 2